Biblio
Export 69 results:
[ Author
Filters: First Letter Of Last Name is N [Clear All Filters]
“Porphyromonas gingivalis Outer Membrane Vesicles as the Major Driver of and Explanation for Neuropathogenesis, the Cholinergic Hypothesis, Iron Dyshomeostasis, and Salivary Lactoferrin in Alzheimer's Disease.”, J Alzheimers Dis, vol. 82, no. 4, pp. 1417-1450, 2021.
, “The Pathology of Rapid Cognitive Decline in Clinically Diagnosed Alzheimer's Disease.”, J Alzheimers Dis, vol. 70, no. 4, pp. 983-993, 2019.
, “Galantamine Response Associates with Agitation and the Prefrontal Cortex in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 1, pp. 267-273, 2017.
, “Death of Dementia Patients in Psychiatric Hospitals and Regional Supply of Psychiatric Services: Study of the National Data from 1996 to 2014 in Japan.”, J Alzheimers Dis, vol. 56, no. 2, pp. 817-824, 2017.
, “Dementia Care Competence Among Care Professionals and Reduced Challenging Behavior of Home-Dwelling Persons with Dementia: A Pre- and Post-Intervention Data Analysis.”, J Alzheimers Dis, vol. 64, no. 2, pp. 515-523, 2018.
, “Costs and Resource Use Associated with Community-Dwelling Patients with Alzheimer's Disease in Japan: Baseline Results from the Prospective Observational GERAS-J Study.”, J Alzheimers Dis, vol. 74, no. 1, pp. 127-138, 2020.
, “Japanese Care Location and Medical Procedures for People with Dementia in the Last Month of Life.”, J Alzheimers Dis, vol. 51, no. 3, pp. 747-55, 2016.
, “A Novel Cognitive Function Scale Using Functional Near-Infrared Spectroscopy for Evaluating Cognitive Dysfunction.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1579-1588, 2021.
, “Apomorphine Therapy for Neuronal Insulin Resistance in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1151-1161, 2017.
, “Preoperative Phosphorylated Tau Concentration in the Cerebrospinal Fluid Can Predict Cognitive Function Three Years after Shunt Surgery in Patients with Idiopathic Normal Pressure Hydrocephalus.”, J Alzheimers Dis, vol. 66, no. 1, pp. 319-331, 2018.
, “In vivo Depiction of α7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1355-1365, 2018.
, “Baseline Predictors of Antipsychotic Treatment Continuation and Response at Week 8 in Patients with Alzheimer's Disease with Psychosis or Aggressive Symptoms: An Analysis of the CATIE-AD Study.”, J Alzheimers Dis, vol. 60, no. 1, pp. 263-272, 2017.
, “Association between Neuropsychiatric Improvement and Neurocognitive Change in Alzheimer's Disease: Analysis of the CATIE-AD Study.”, J Alzheimers Dis, vol. 66, no. 1, pp. 139-148, 2018.
, “Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study.”, J Alzheimers Dis, vol. 50, no. 3, pp. 839-45, 2016.
, “Visit-to-Visit Blood Pressure Variability and Alzheimer's Disease: Links and Risks.”, J Alzheimers Dis, vol. 59, no. 2, pp. 515-526, 2017.
, “Astrocytes release HspB1 in response to amyloid-β exposure in vitro.”, J Alzheimers Dis, vol. 49, no. 1, pp. 251-63, 2016.
, “Genetic Heterogeneity of Alzheimer's Disease: Embracing Research Partnerships.”, J Alzheimers Dis, vol. 62, no. 3, pp. 903-911, 2018.
, “Combinational Drug Repurposing from Genetic Networks Applied to Alzheimer's Disease.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1585-1603, 2022.
, “Comprehensive Screening for Disease Risk Variants in Early-Onset Alzheimer's Disease Genes in African Americans Identifies Novel PSEN Variants.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1215-1222, 2017.
,